$15.10
-0.03-0.20%
Last update: Dec 15, 9:56 AM
Comments
Loading...
Coeptis Therapeutics (COEP) Stock Price, Quote, News & History
COEPNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Coeptis Therapeutics (COEP) stock?
You can purchase shares of Coeptis Therapeutics (NASDAQ:COEP) through any online brokerage.
Who are Coeptis Therapeutics (COEP) competitors?
Other companies in Coeptis Therapeutics’s space includes: Macrogenics Inc (NASDAQ:MGNX), Outlook Therapeutics Inc (NASDAQ:OTLK), Tharimmune Inc (NASDAQ:THAR), Korro Bio Inc (NASDAQ:KRRO) and Aligos Therapeutics Inc (NASDAQ:ALGS).
What is the forecast, or price target, for Coeptis Therapeutics (COEP) stock?
Coeptis Therapeutics has a consensus price target of $5.67.
What is the current price for Coeptis Therapeutics (COEP)?
The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $15.1 last updated December 15, 2025 at 9:56 AM EST.
Does Coeptis Therapeutics (COEP) pay a dividend?
There are no upcoming dividends for Coeptis Therapeutics.
When is Coeptis Therapeutics (NASDAQ:COEP) reporting earnings?
Coeptis Therapeutics does not have any upcoming earnings scheduled.
Is Coeptis Therapeutics (COEP) going to split?
There is no upcoming split for Coeptis Therapeutics.
What sector and industry does Coeptis Therapeutics (COEP) operate in?
Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
